Cancers of the breast and prostate are one of the leading causes of cancer deaths in women and men, respectively. Although several treatment options have been developed to transform these cancers into manageable chronic diseases, they still contribute to over 70,000 deaths each year in the United States. Though majority of these cancers belong to slow growing differentiated subtypes, the cancers evolve over time due to treatment-related pressure into aggressive treatment-resistant types. A mecha
Role of JAK-STAT Signaling Pathway in Hormonal Cancer Therapeutic Resistance and Lineage Plasticity
Wendy Effah·Ramesh Narayanan·Sanskrita Sukla·Chenhao Zhao·Suriyan Ponnusamy·Lawrence M Pfeffer·Hyo Young Choi·Marjana Khalil
